LGT Fund Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.7M Buy
857,783
+48,979
+6% +$1.28M 0.86% 23
2026
Q1
$22.7M Buy
808,804
+765,044
+1,748% +$20.4M 0.99% 19
2025
Q4
$1.09M Buy
43,760
+15,700
+56% +$396K 0.09% 152
2025
Q3
$764K Buy
28,060
+5,010
+22% +$124K 0.06% 166
2025
Q2
$559K Sell
23,050
-20,500
-47% -$478K 0.05% 179
2025
Q1
$1.1M Sell
43,550
-62,010
-59% -$1.62M 0.1% 143
2024
Q4
$2.8M Sell
105,560
-437,000
-81% -$11.9M 0.25% 87
2024
Q3
$15.5M Buy
542,560
+141,788
+35% +$4.14M 1.61% 14
2024
Q2
$11.2M Buy
400,772
+392,272
+4,615% +$10.8M 1.4% 18
2024
Q1
$236K Buy
+8,500
New +$236K 0.1% 117
2023
Q3
Sell
-8,600
Closed -$315K 122
2023
Q2
$315K Sell
8,600
-4,850
-36% -$189K 0.14% 91
2023
Q1
$549K Buy
13,450
+3,570
+36% +$154K 0.23% 82
2022
Q4
$506K Buy
9,880
+680
+7% +$32.6K 0.22% 72
2022
Q3
$403K Sell
9,200
-160,571
-95% -$7.8M 0.19% 79
2022
Q2
$8.9M Buy
169,771
+79,359
+88% +$4.04M 1.31% 14
2022
Q1
$4.66M Buy
90,412
+79,112
+700% +$4.1M 0.62% 38
2021
Q4
$667K Buy
+11,300
New +$560K 0.19% 80

Other funds holding PFE

LGT Fund Management's PFE Position: Q2 2026 in Review

LGT Fund Management increased its Pfizer (PFE) stake by 6.1% in Q2 2026, buying an estimated $1.28M and bringing the position to 857,783 shares worth $20.7M. The position accounts for 0.86% of the portfolio, ranked #23.

LGT Fund Management first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. The position peaked at $22.7M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • LGT Fund Management held 857,783 shares of Pfizer worth $20.7M as of Q2 2026.
  • LGT Fund Management bought 48,979 Pfizer shares in Q2 2026, an estimated $1.28M.
  • Pfizer made up 0.86% of LGT Fund Management's portfolio in Q2 2026, its #23 holding.
  • LGT Fund Management first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
  • LGT Fund Management's Pfizer position peaked at $22.7M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.